col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


29 Ergebisse       Seite 1

 [1] 
Springer Science and Business Media LLC: npj Viruses
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2025―Apr―01 Balancing stability and function: impact of the surface charge of SARS-CoV-2 Omicron spike protein Daniel Lauster, Rainer Haag, Matthias Ballauff, Andreas Herrmann
2 [GO] 2025―Mrz―13 Potent bivalent nanobody constructs that protect against the SARS-CoV-2 XBB variant Peter J. Halfmann, Jeong Soo Lee, Nikki McArthur, Ojas Gupta, Yoshihiro Kawaoka, Ravi S. Kane
3 [GO] 2025―Feb―24 Pathogenesis and transmission of SARS-CoV-2 D614G, Alpha, Gamma, Delta, and Omicron variants in golden hamsters Andra Banete, Bryan D. Griffin, Juan C. Corredor, Emily Chien, Lily Yip, Tarini N. A. Gunawardena, et al. (+29)
4 [GO] 2025―Feb―03 An XBB.1.5-based inactivated SARS-CoV-2 vaccine partially protects against XBB.1.5 and JN.1 strains in hamsters Ryuta Uraki, Mutsumi Ito, Maki Kiso, Kiyoko Iwatsuki-Horimoto, Masafumi Endo, Seiya Yamayoshi, Yoshihiro Kawaoka
5 [GO] 2024―Dez―30 Middle East respiratory syndrome coronavirus (MERS-CoV) internalization does not rely on DPP4 cytoplasmic tail signaling Karthika Thankamani, Divakar Shubham, Gayatri Kandpal, Ann Mary Isaac, Modenkattil Sethumadhavan Kavitha, V. Stalin Raj
6 [GO] 2024―Dez―30 Automated and virus variant-programmable surrogate test qualitatively compares to the gold standard SARS-CoV-2 neutralization assay Danielle W. Ali, Maggie L. Bartlett, Christopher D. Heger, Francisco Ramirez, Linwood Johnson, Kevin L. Schully, et al. (+14)
7 [GO] 2024―Dez―17 A portrait of the infected cell: how SARS-CoV-2 infection reshapes cellular processes and pathways Valentina Marano, Štěpánka Vlachová, Sofia Maria Luigia Tiano, Mirko Cortese
8 [GO] 2024―Nov―21 Reduced cross-protective potential of Omicron compared to ancestral SARS-CoV-2 spike vaccines against potentially zoonotic coronaviruses Tyler M. Renner, Matthew Stuible, Brian Cass, Sylvie Perret, Julie Guimond, Simon Lord-Dufour, et al. (+3)
9 [GO] 2024―Nov―21 Sensitivity of rodents to SARS-CoV-2: Gerbils are susceptible to SARS-CoV-2, but guinea pigs are not Kiyoko Iwatsuki-Horimoto, Maki Kiso, Mutsumi Ito, Seiya Yamayoshi, Yoshihiro Kawaoka
10 [GO] 2024―Nov―14 Potent neutralization by a RBD antibody with broad specificity for SARS-CoV-2 JN.1 and other variants Michael S. Piepenbrink, Ahmed Magdy Khalil, Ana Chang, Ahmed Mostafa, Madhubanti Basu, Sanghita Sarkar, et al. (+14)
11 [GO] 2024―Nov―05 Characterization of a SARS-CoV-2 Omicron BA.5 direct-contact transmission model in hamsters Kim Handrejk, Katharina S. Schmitz, Edwin J. B. Veldhuis Kroeze, Laura L. A. van Dijk, Peter van Run, Bart Haagmans, et al. (+5)
12 [GO] 2024―Okt―17 Discordant phylodynamic and spatiotemporal transmission patterns driving the long-term persistence and evolution of human coronaviruses Marcus G. Mah, Michael A. Zeller, Rong Zhang, Yan Zhuang, Venance P. Maro, John A. Crump, et al. (+6)
13 [GO] 2024―Sep―02 Resistance to SARS-CoV-2 infection in camelid nasal organoids is associated with lack of ACE2 expression Tim I. Breugem, Samra Riesebosch, Debby Schipper, Anna Z. Mykytyn, Petra van den Doel, Joaquim Segalés, et al. (+2)
14 [GO] 2024―Aug―24 SARS-CoV-2 infection results in a unique lung proteome long after virus resolution in the hamster Amrit S. Boese, Bryce M. Warner, Peter McQueen, Robert Vendramelli, Nikesh Tailor, Bryan D. Griffin, et al. (+7)
15 [GO] 2024―Aug―23 Beyond COVID-19: the promise of next-generation coronavirus vaccines Reshma Koolaparambil Mukesh, Claude K. Yinda, Vincent J. Munster, Neeltje van Doremalen
16 [GO] 2024―Aug―22 Transmission dynamics of MERS-CoV in a transgenic human DPP4 mouse model Neeltje van Doremalen, Trenton Bushmaker, Robert J. Fischer, Atsushi Okumura, Dania M. Figueroa Acosta, Rebekah J. McMinn, et al. (+4)
17 [GO] 2024―Aug―06 Vaccination with ancestral SARS-CoV-2 spike adjuvanted with TLR agonists provides cross-protection against XBB.1 Stephanie K. Lathrop, Jordan J. Clark, Karthik Siram, Robert Andreata-Santos, Jeremy Yong, Rebekah D. Tee, et al. (+5)
18 [GO] 2024―Jul―16 Jamaican fruit bat (Artibeus jamaicensis) insusceptibility to mucosal inoculation with SARS-CoV-2 Delta variant is not caused by receptor compatibility Julia R. Port, Jade C. Riopelle, Sarah van Tol, Arthur Wickenhagen, Eric Bohrnsen, Daniel E. Sturdevant, et al. (+14)
19 [GO] 2024―Jul―09 Evolution at Spike protein position 519 in SARS-CoV-2 facilitated adaptation to humans C. Cereghino, K. Michalak, S. DiGiuseppe, J. Guerra, D. Yu, A. Faraji, et al. (+5)
20 [GO] 2024―Jun―24 Study of key residues in MERS-CoV and SARS-CoV-2 main proteases for resistance against clinically applied inhibitors nirmatrelvir and ensitrelvir Laura Krismer, Helge Schöppe, Stefanie Rauch, David Bante, Bernhard Sprenger, Andreas Naschberger, et al. (+7)
21 [GO] 2024―Jun―03 Tracing household transmission of SARS-CoV-2 in New Zealand using genomics Lauren Jelley, Nayyereh Aminisani, Meaghan O’Neill, Tineke Jennings, Jordan Douglas, Srushti Utekar, et al. (+40)
22 [GO] 2024―Feb―21 The Wnt/β-catenin pathway is important for replication of SARS-CoV-2 and other pathogenic RNA viruses Zaikun Xu, Mohamed Elaish, Cheung Pang Wong, Bardes B. Hassan, Joaquin Lopez-Orozco, Alberto Felix-Lopez, et al. (+10)
23 [GO] 2024―Feb―14 Revealing the significance of IL-2 and IL-5 in SARS-CoV-2-specific T-cell responses in kidney transplant recipients Yvette den Hartog, S. Reshwan K. Malahe, Wim J. R. Rietdijk, Marjolein Dieterich, Lennert Gommers, Debbie van Baarle, et al. (+32)
24 [GO] 2024―Jan―09 Airborne transmission efficiency of SARS-CoV-2 in Syrian hamsters is not influenced by environmental conditions Claude Kwe Yinda, Julia R. Port, Trenton Bushmaker, Jonathan E. Schulz, Shane Gallogly, Robert J. Fischer, Vincent J. Munster
25 [GO] 2023―Dez―13 Singapore COVID-19 data cross-validation by the Gaidai reliability method Oleg Gaidai, Vladimir Yakimov, Jiayao Sun, Eric-Jan van Loon
26 [GO] 2023―Dez―13 Survey of white-footed mice (Peromyscus leucopus) in Connecticut, USA reveals low SARS-CoV-2 seroprevalence and infection with divergent betacoronaviruses Rebecca Earnest, Anne M. Hahn, Nicole M. Feriancek, Matthew Brandt, Renata B. Filler, Zhe Zhao, et al. (+18)
27 [GO] 2023―Dez―05 Rural populations facilitated early SARS-CoV-2 evolution and transmission in Missouri, USA Cynthia Y. Tang, Tao Li, Tricia A. Haynes, Jane A. McElroy, Detlef Ritter, Richard D. Hammer, et al. (+4)
28 [GO] 2023―Nov―14 Evolutionary trajectory of SARS-CoV-2 genome shifts during widespread vaccination and emergence of Omicron variant Kaitlyn Gayvert, Sheldon McKay, Wei Keat Lim, Alina Baum, Christos Kyratsous, Richard Copin, Gurinder S. Atwal
29 [GO] 2023―Okt―18 Novel mechanism of the COVID-19 associated coagulopathy (CAC) and vascular thromboembolism Mahavir Singh, Sathnur Pushpakumar, Yuting Zheng, Irina Smolenkova, Oluwaseun E. Akinterinwa, Bana Luulay, Suresh C. Tyagi
 [1] 

29 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.003 sec